Preoperative chlorhexidine baths/showers: for or against?

Surgical site infections (SSIs) are a major health care-related problem in Brazil. SSIs are considered the third most prevalent sort of infection in our country. A national study carried out by the Ministry of Health of Brazil in 1999 found SSI in 11% of all surgical procedures analyzed.1 The recent review article by Chlebicki et al,2 whose metaanalysis suggested no benefit of using chlorhexidine to prevent SSI, sparked a debate in our service regarding our practice of chlorhexidine use. Chlorhexidine is a broad-spectrum topical antiseptic agent capable of decreasing colonization by bacteria from the skin with effectiveness againstmultidrug-resistant organisms (eg, methicillinresistant Staphylococcus aureus, vancomycin-resistant Enterococcus).3 This antiseptic agent has the potential to prevent other types of health-related infections besides SSIs. A recent randomized clinical trial published by Climo et al4 studied the effect of daily bathing/showering with chlorhexidine in preventing nosocomial bloodstream infections in patients admitted to intensive care units. This multicenter study assessed 7,727 patients and observed a significant decrease in bloodstream infection rates in patients at risk for infection. Considering that the effect of chlorhexidine is a topical one, we believe that the inclusion of contaminated surgeries in the meta-analysis was inappropriate, although a subgroup analysis excluding these surgeries did not change the results. Furthermore, preoperative prophylaxis differed among the studies, possibly contributing to the differences in outcome. Analyzing the types of surgeries covered in the studies reveals a remarkable diversity of surgical sites, which could affect infection risk based on timing and complexity of surgical procedures and disease severity. Interestingly, the meta-analysis and randomized clinical trial had a similar number of patients. Despite the different methodologies